Etienne Lengliné

10PUBLICATIONS
41CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methodsHaematological tumoursNanotoxicology, health and safetyCentral nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 19, 2026
Health-related quality of life reporting in randomized controlled trials of chimeric antigen receptor T-cell therapy: A systematic review of dedicated publications.

|Mar 24, 2026
When evaluating targeted therapies in chronic lymphocytic leukemia, the absolute measure of treatment effect should be preferred.

Vincent Lévy, Etienne Lengline, Sylvie Chevret

|Aug 26, 2025
LEF1 intragenic deletion induces a dominant-negative isoform and unveils a Wnt/β-catenin vulnerability in T-ALL.

Manon Delafoy, Mickaël F Bonnet, Etienne Lengliné

|Dec 09, 2024
How do we respond to the threat of multidrug-resistant bacteria? Comparison of antibiotic appraisals from 2016 to 2020 of the French, English, and German HTA agencies.

Rémy Dumont, Etienne Lengliné, Clara Delorme

|Jun 25, 2024
Cerebrospinal fluid distribution and pharmacokinetics of ponatinib in Ph1+ acute lymphoblastic leukemia.

Pierre Walczak, Sofiane Fodil, Nicolas Vignal

|Mar 20, 2024
Blinatumomab consolidation for adult B-cell acute lymphoblastic leukemia in first and second complete remission.

Irene Urbino, Etienne Lengliné, Florence Rabian

Pageof 2

Frequent Collaborators

4 joint publications

Nicolas Boissel

3 joint publications

Sylvie Chevret

2 joint publications

Hervé Dombret

1 joint publications

Colombe Saillard